Caboodles
This article was originally published in The Rose Sheet
Executive Summary
Investment consultant Charles Beech tapped as acting CEO after agreeing to provide teen cosmetics brand with influx of capital during transition period, following departure of President Gary Schofield in May, Plano Molding Company division says. Additional higher level management staff may be hired in the near term, company adds. Caboodles is reportedly for sale...
You may also be interested in...
Caboodles Cosmetics
Sale of teen cosmetics line to private equity investment firm Pittco Capital Partners and select members of management is complete, the company announces. New capital will be used to add management, marketing and other resources to the firm, helping it to "reach its potential," Caboodles says. Investment consultant Charles Beech will serve as chairman and CEO of the new company. Experienced cosmetics exec, who has worked for Maybelline and Procter & Gamble, was tapped as acting CEO of Caboodles last year following the departure of Gary Schofield in May (1"The Rose Sheet" June 16, 2003, In Brief). Formerly owned by Plano Molding Company, the company also markets department store brands She She and C Me in addition to the mass market Caboodles line...
IGI Bets On Trispecific Antibody To Make Inroads Into Big Pharma Myeloma Turf
Ichnos Glenmark Innovation’s president and CEO talks to Scrip about the promising activity profile of the alliance’s early stage trispecific antibody versus Janssen’s teclistamab and also maintains that the setback for Gilead’s magrolimab hasn’t eclipsed prospects for its bispecific antibody.
UK Medtech Strategy Sets Out Schedule Of Milestones To FY 2026
Fourteen months on from the release of its inaugural medtech strategy, the UK MedTech Directorate has laid firm foundations and reports progress on initiatives aimed at improving technology adoption. A schedule of ambitious future timelines has also been published.